Neurelis Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NEURELIS INC, and when can generic versions of NEURELIS INC drugs launch?
NEURELIS INC has one approved drug.
There are six US patents protecting NEURELIS INC drugs.
There are eighty-seven patent family members on NEURELIS INC drugs in twenty-eight countries.
Summary for Neurelis Inc
| International Patents: | 87 |
| US Patents: | 6 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Neurelis Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-002 | Jan 10, 2020 | RX | Yes | No | 9,642,913 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-002 | Jan 10, 2020 | RX | Yes | No | 11,793,786 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-001 | Jan 10, 2020 | RX | Yes | No | 11,241,414 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-002 | Jan 10, 2020 | RX | Yes | No | 8,927,497 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
